🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

10 recruiting trials

for Hyperphosphatemia

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China NCT06933472Phase 342 sites📍 Granada Hills📍 San Dimas📍 San Dimas Alebund Pharmaceuticals · Tests: AP301, AP301 Low Dose Multicenter, Open, Prospective, 48 Weeks, Observational Study ,Evaluate the Safety and Efficacy of Nephoxil Capsule NCT06206135n/a1 site📍 Jeonju LG Chem · Tests: the low-dose group (1.5 g/day) or the standard-dose group (4 g/day) A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia NCT06712654Phase 231 sites📍 Huntsville📍 Chula Vista📍 Los Angeles R1 Therapeutics · Tests: AP306 75 mg BID, AP306 125 mg BID, AP306 150 mg BID, AP306 75 mg TID, AP306 100 mg TID Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) NCT04278404n/a52 sites📍 Phoenix📍 Little Rock📍 Los Angeles Duke University · Tests: The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the fol… A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders NCT07285291Phase 31 site📍 Tokyo Taisho Pharmaceutical Co., Ltd. · Tests: TS-172 20~60 mg/day, Placebo A Clinical Study of TS-172 in Hyperphosphatemia Patients on Peritoneal Dialysis NCT07548853Phase 31 site📍 Tokyo Taisho Pharmaceutical Co., Ltd. · Tests: 'TS-172 20~60 mg/day Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemia NCT06664125Phase 22 sites📍 Guangzhou📍 Guangzhou Jemincare · Tests: JMKX003002 will be administered orally, Sevelamer carbonate Phosphate in Acute Pancreatitis NCT07681050Phase 21 site📍 Durham Duke University · Tests: Sodium Phosphate, Potassium Phosphate Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE) NCT03573089NA126 sites📍 Camperdown📍 Kingswood📍 Kogarah The University of Queensland · Tests: Liberal phosphate target, Intensive phosphate target A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis NCT07285304Phase 31 site📍 Tokyo Taisho Pharmaceutical Co., Ltd. · Tests: TS-172
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy